Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Statistics

Total Valuation

RLAY has a market cap or net worth of $533.19 million. The enterprise value is -$130.00 million.

Market Cap	533.19M
Enterprise Value	-130.00M

Important Dates

The last earnings date was Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

RLAY has 171.44 million shares outstanding. The number of shares has increased by 22.01% in one year.

Current Share Class	171.44M
Shares Outstanding	171.44M
Shares Change (YoY)	+22.01%
Shares Change (QoQ)	+1.13%
Owned by Insiders (%)	2.03%
Owned by Institutions (%)	71.01%
Float	121.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	61.75
Forward PS	102.83
PB Ratio	0.74
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.96, with a Debt / Equity ratio of 0.07.

Current Ratio	19.96
Quick Ratio	19.17
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.46% and return on invested capital (ROIC) is -30.19%.

Return on Equity (ROE)	-45.46%
Return on Assets (ROA)	-28.82%
Return on Invested Capital (ROIC)	-30.19%
Return on Capital Employed (ROCE)	-49.63%
Revenue Per Employee	$29,421
Profits Per Employee	-$1.28M
Employee Count	261
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.56% in the last 52 weeks. The beta is 1.65, so RLAY's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	-51.56%
50-Day Moving Average	2.97
200-Day Moving Average	5.05
Relative Strength Index (RSI)	53.25
Average Volume (20 Days)	2,740,662

Short Selling Information

The latest short interest is 19.47 million, so 11.36% of the outstanding shares have been sold short.

Short Interest	19.47M
Short Previous Month	18.36M
Short % of Shares Out	11.36%
Short % of Float	16.04%
Short Ratio (days to cover)	6.02

Income Statement

In the last 12 months, RLAY had revenue of $7.68 million and -$333.39 million in losses. Loss per share was -$2.19.

Revenue	7.68M
Gross Profit	-299.17M
Operating Income	-378.35M
Pretax Income	-322.83M
Net Income	-333.39M
EBITDA	-373.07M
EBIT	-378.35M
Loss Per Share	-$2.19

Balance Sheet

The company has $710.36 million in cash and $47.16 million in debt, giving a net cash position of $663.20 million or $3.87 per share.

Cash & Cash Equivalents	710.36M
Total Debt	47.16M
Net Cash	663.20M
Net Cash Per Share	$3.87
Equity (Book Value)	721.08M
Book Value Per Share	4.23
Working Capital	702.61M

Cash Flow

In the last 12 months, operating cash flow was -$271.99 million and capital expenditures -$622,000, giving a free cash flow of -$272.62 million.

Operating Cash Flow	-271.99M
Capital Expenditures	-622,000
Free Cash Flow	-272.62M
FCF Per Share	-$1.59

Margins

Gross Margin	n/a
Operating Margin	-4,927.05%
Pretax Margin	-4,341.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.01%
Shareholder Yield	-22.01%
Earnings Yield	-62.53%
FCF Yield	-51.13%

Analyst Forecast

The average price target for RLAY is $18.40, which is 491.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.40
Price Target Difference	491.64%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	101.55%
EPS Growth Forecast (5Y)	-46.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RLAY has an Altman Z-Score of 3.06 and a Piotroski F-Score of 1.

Altman Z-Score	3.06
Piotroski F-Score	1